Page 316 - IJB-10-1
P. 316

International Journal of Bioprinting                            Low-cost quad-extrusion 3D bioprinting system




            based hydrogels, as well as different applications such as   validation testing toward satisfying the requirements and
            vascular constructs. Moreover, the QEH is being modified   regulations that render the bioprinter to be compliant
            to be able to accommodate syringes with larger volumes for   with the current Good Manufacturing Practices (cGMP)
            more scaled-up tissue models and organs. Furthermore,   as set by federal agencies, such as the U.S. Food and Drug
            to enable further capabilities of reliable non-planar 3D   Administration (FDA).
            bioprinting, a three-axis rotary stage is being designed and
            developed. This would render a substrate that can rotate   6. Conclusion
            to keep the nozzle orthogonal to the non-planar printing   In this work, a low-cost quad-extrusion multi-material
            surface of pre-existing or pre-printed structures.  bioprinter was initially derived from an off-the-shelf
               For more accurate structural outcomes, it is important   desktop 3D printer, Creality Ender 3 Pro. The developed
            to be able to precisely control the material parameters   QEB was designed and fabricated in-house and validated
            involved in bioprinting. From a material standpoint, one   through several printed structures using two different
            main material property to be tuned would be the bioink   printing paradigms, namely, IAP and SBP. The novel design
            viscosity, which is controlled by the bioink temperature.   enables multi-material bioprinting at a very low cost,
            The optimum viscosity value can then be transferred to   overcoming the issues of affordability and scalability that
            other types of bioink material by controlling the bioink   currently hamper the present designs as reported in current
            temperature. To realize and attain the desired bioink   literature. Moreover, the challenges that traditionally
            viscosity, an  in situ viscosity measurement system is   accompany multi-material printing, like nozzle alignment,
            currently being developed to allow the determination of   calibration, and diminished printing volumes, are
            that optimal viscosity value, from which the temperature   overcome with the compactness of the bioprinter design
            to be set would be known and actively controlled during   presented herein. In addition to the  latter advantages,
            printing. This is being done in conjunction with real-time   the QES developed can be transferred to any other open-
            image processing and machine learning algorithms to   frame desktop 3D printer to render a fully functional
            verify the compliance of the printed structures with the   bioprinter. Moreover, the bioprinted constructs produced
            designed CAD models. This would enable a better flow of   under variable process conditions are then characterized
            bioink with enhanced structural fidelity. To be sure, due   structurally and biologically to verify the geometric fidelity
            to the lack of temperature control and different printing   of the bioprinted outcomes, as well as cell viability and cell
            mechanisms, the QEB would be limited with the range of   function within those constructs. This signifies a great step
            different materials it can process, including thermoplastics   further toward the availability and affordability of additive
            and other hard materials that can be used for biological   manufacturing for biological applications since the current
            applications.                                      techniques and technologies are still complex and at a
                                                               very  high cost.  With the advancement  of this  QEB, it
               Another  limitation  of  multi-material  printing  is the   becomes feasible to extend the reach of such life-changing
            interlayer adhesion strength between different material   technologies to the general public at an accessible price
            interfaces. This may be caused by the different properties   point.
            and constituents of the different materials. To overcome
            such limitations, different design approaches can be   Further development to the QEB is under progress to
            followed, like the modification of CAD models and   include an onboard UV light source attached adjacent to
            toolpaths, to account for the weak interfacial adhesion. This   the nozzle that allows instant crosslinking, either during
            can be done by setting a small inset at the multi-material   or after printing. Also, an active heating system that
            interfaces to allow stronger bonding and links between the   allows precise control of the bioink and support bath (SB)
            different bioinks at boundary interfaces.          temperatures, in combination with a real-time viscosity
                                                               measurement system, is being developed to optimize the
               With the aforementioned developments, along with the   bioink viscosity that would render the best structural
            expansion of the QEH to make it modular and compatible   outcomes. Furthermore, a microfluidic nozzle extension
            with several extrusion mechanisms, the scalability of the   to the present QEH is being designed to allow the micro-
            QEB would become possible with the added attributes   mixing of the different materials that are amenable to render
            such  as increased reliability,  robustness,  and versatility.   new bioinks with different combinations or gradients
            This would facilitate significant contributions to various   from the separate four bioinks. The QEB with these low-
            engineered tissue applications that are currently out of   cost upgrades would even further expand the range of
            the reach of current bioprinting capabilities. Moreover,   applications that can be achieved with such an affordable
            in order to translate bioprinting studies into clinical use,   and capable extrusion system, with high reliability and
            it will be necessary to ensure process reliability with   repeatability.

            Volume 10 Issue 1 (2024)                       308                        https://doi.org/10.36922/ijb.0159
   311   312   313   314   315   316   317   318   319   320   321